Histology and Cytology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Histology and Cytology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global histology and cytology market size reached US$ 15.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2028, exhibiting a growth rate (CAGR) of 10.7% during 2023-2028.

Histology and cytology are branches of biology dealing with chemistry, structure and function of tissues and cells of animals and plants at a microscopic level. They assist medical staff in diagnosing diseases, such as cancer, cervical disease, tuberculosis, human papilloma virus (HPV) infection, abnormal growth, inflammatory diseases, leukemia, smallpox, and rabies. They also help enhance the sensitivity, specificity and accuracy of diagnostic methods. As a result, they find extensive applications in hospitals, clinics, and research and development (R&D) institutes across the globe.

Histology and Cytology Market Trends:
At present, there is a rise in the number of cancer patients across the globe. This, along with the favorable reimbursement policies for laboratory tests, represents one of the key factors driving the market. Moreover, the growing integration of digital solutions in cytological diagnosis aids in rapidly interpreting primary diagnostic data, which is positively influencing the market. In addition, major manufacturers are launching new and advanced cytology systems for helping in the rapid on-site evaluation of cytology samples. This, coupled with the rising traction of immunohistochemistry (IHC) for visualizing cellular components, is propelling the growth of the market. Besides this, there is an increase in the standardization of pathological laboratories around the world. This, along with technological advancements in diagnostic and molecular techniques, is contributing to the growth of the market. Additionally, increasing awareness about the advanced therapeutics and enhanced healthcare infrastructure worldwide is offering lucrative growth opportunities to industry investors. Furthermore, key market players are focusing on acquisitions, mergers, partnerships, and collaborations to expand their customer base. They are also launching new products and receiving product approvals from regulatory authorities, which is projected to bolster the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global histology and cytology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type of examination, test type and application.

Breakup by Product:

Instruments and Analysis Software System
Consumable and Reagents

Breakup by Type of Examination:

Histology
Cytology

Breakup by Test Type:

Microscopy Tests
Molecular Genetics Tests
Flow Cytometry

Breakup by Application:

Drug Discovery and Designing
Clinical Diagnostics
Point-of-Care (PoC)
Non-Point-of-Care
Research

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc. and Trivitron Healthcare.

Key Questions Answered in This Report

1. What was the size of the global histology and cytology market in 2022?
2. What is the expected growth rate of the global histology and cytology market during 2023-2028?
3. What are the key factors driving the global histology and cytology market?
4. What has been the impact of COVID-19 on the global histology and cytology market?
5. What is the breakup of the global histology and cytology market based on the product?
6. What is the breakup of the global histology and cytology market based on the type of examination?
7. What is the breakup of the global histology and cytology market based on test type?
8. What is the breakup of the global histology and cytology market based on the application?
9. What are the key regions in the global histology and cytology market?
10. Who are the key players/companies in the global histology and cytology market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Histology and Cytology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Instruments and Analysis Software System
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumable and Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Examination
7.1 Histology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cytology
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Test Type
8.1 Microscopy Tests
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Molecular Genetics Tests
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Flow Cytometry
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Drug Discovery and Designing
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinical Diagnostics
9.2.1 Market Trends
9.2.2 Key Segments
9.2.2.1 Point-of-Care (PoC)
9.2.2.2 Non-Point-of-Care
9.2.3 Market Forecast
9.3 Research
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Carl Zeiss AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 F. Hoffmann-La Roche AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Hologic Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Koninklijke Philips N.V.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Merck KGaA
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Olympus Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 PerkinElmer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sysmex Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Trivitron Healthcare
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings